RE:RE:alot different Transaction Details
The total purchase price will consist of cash consideration of approximately £800 million (approximately US$1.2 billion), 8.49 million common shares of Concordia (approximately US$0.7 billion), and the assumption of approximately US$1.4 billion AMCo net debt upon closing, as well as a maximum performance-based earn-out of £144 million payable in cash in the fourth quarter of 2016 (approximately US$220 million). Following the closing of the transaction, Concordia will own a 100% stake in AMCo, and Cinven will hold an expected 19.9% ownership in Concordia on a non-diluted basis and before giving effect to the anticipated equity offering (referenced below).
Read more at https://www.stockhouse.com/news/press-releases/2015/09/08/concordia-healthcare-to-acquire-amdipharm-mercury-limited-amco-for-us-3-5#kRhxBSErVlpksvgP.99
Lots of shares issued. Not sure if I like the idea of Cinven now owning 19.9% of CXR now.